TIAA CREF Investment Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-79,147
Closed -$7.72M 3246
2015
Q1
$7.72M Buy
79,147
+3,947
+5% +$385K 0.01% 1329
2014
Q4
$6.98M Sell
75,200
-7,827
-9% -$726K ﹤0.01% 1390
2014
Q3
$5.71M Sell
83,027
-4,762
-5% -$328K ﹤0.01% 1510
2014
Q2
$9.2M Buy
87,789
+6,858
+8% +$719K 0.01% 1218
2014
Q1
$6.72M Sell
80,931
-1,390
-2% -$115K ﹤0.01% 1404
2013
Q4
$5.33M Buy
82,321
+6,531
+9% +$423K ﹤0.01% 1598
2013
Q3
$4.8M Buy
75,790
+537
+0.7% +$34K ﹤0.01% 1610
2013
Q2
$3.16M Buy
+75,253
New +$3.16M ﹤0.01% 1862